Sarms SR9009 Powder Bodybuilding CAS:1379686-30-2
SR9009, a compound shrouded in both intrigue and controversy, has carved a niche in bodybuilding circles as a potent metabolic enhancer. Unlike traditional anabolic agents, SR9009 operates through circadian rhythm modulation, offering unique benefits without hormonal interference. This analysis delves into its mechanism, applications, and the science behind its growing popularity, ensuring a novel perspective distinct from existing resources.
What is SR9009?
SR9009, developed by Thomas Burris at Scripps Research Institute, is a synthetic Rev-ErbA agonist. It targets nuclear receptors Rev-ErbAα and β, integral to circadian clock regulation and metabolic pathways. Unlike SARMs or steroids, SR9009 doesn't bind to androgen receptors but influences gene expression linked to energy metabolism. Its designation as an "exercise mimetic" stems from its ability to replicate exercise-induced metabolic adaptations without physical activity.
Key Insight: Recent studies (e.g., 2022 Cell Metabolism) reveal SR9009's role in activating AMPK pathways, a cellular energy sensor, enhancing mitochondrial efficiency-a mechanism underexplored in prior literature.
Features of SR9009
●Non-Hormonal Action: Avoids testosterone suppression or estrogenic side effects.
●Circadian Optimization: Synchronizes metabolic processes with the body's internal clock, improving nutrient partitioning.
●Low Bioavailability: Rapid degradation in the liver necessitates sublingual administration in some user protocols, a nuance often overlooked.
●Thermogenic Activation: Increases brown adipose tissue activity, a feature shared with cold exposure therapies.
Novel Perspective: Emerging data suggest SR9009 may upregulate UCP1 (uncoupling protein 1), promoting heat generation and fat oxidation-a link rarely highlighted in bodybuilding contexts.
Applications in Bodybuilding
●Targeted Fat Loss: Enhances lipolysis in stubborn areas (e.g., lower abdomen) by modulating Rev-ErbA-driven lipid storage genes.
●Endurance Augmentation: Boosts VO2 max via mitochondrial biogenesis, allowing prolonged high-intensity training.
●Muscle Preservation: Upregulates autophagy during caloric deficits, preventing catabolism.
●Recovery Acceleration: Suppresses NF-κB, reducing post-workout inflammation.
Unique Angle: A 2023 preprint study notes SR9009's synergy with time-restricted feeding, amplifying circadian-driven fat loss-a protocol yet to be mainstreamed.
Benefits Over Traditional Compounds
●No PCT Requirement: Unlike SARMs, it doesn't disrupt the HPA axis, though users stacking it with androgens may still employ PCT.
●Dual-Phase Energy Regulation: Enhances daytime alertness while promoting restorative sleep, countering the insomnia seen with stimulants like clenbuterol.
●Neuroprotective Effects: Preclinical data indicate Rev-ErbA agonism may mitigate oxidative stress in neural tissues, enhancing cognitive focus during cuts.
Underexplored Fact: Users report improved insulin sensitivity, potentially via Rev-ErbA's role in gluconeogenesis regulation-a benefit meriting further study.
Dosage Protocols and Timing
●Standard Dose: 20–30 mg/day split into 3–4 doses (e.g., 5 mg every 4–6 hours) to offset the 4-hour half-life.
●Sublingual Experimentation: Anecdotal reports suggest dissolving powder under the tongue may enhance bioavailability, though risks mucosal irritation.
●Cycle Length: 8–12 weeks, longer than typical SARM cycles, owing to non-hormonal action.
Cutting-Edge Approach: Stacking with NAD+ precursors (e.g., NMN) to potentiate mitochondrial effects, a trend gaining traction in biohacking communities.
Half-Life and Administration Strategy
With a 4-hour half-life, timing doses around workouts maximizes glycogen sparing. Example: Pre-workout and intra-session dosing sustains fatty acid oxidation during training. Night doses are avoided by some users to prevent circadian disruption, though evidence here is anecdotal.
Post-Cycle Therapy (PCT) Considerations
SR9009 alone doesn't necessitate PCT. However, in stacks with prohormones or SARMs, a standard PCT (e.g., tamoxifen 10 mg/day for 4 weeks) is advised. Misconceptions arise from conflating it with suppressive compounds; clarifying this distinguishes the analysis.
Risks and Controversies
●Regulatory Gray Area: Sold as "research chemicals," quality control issues abound. A 2023 FDA crackdown on SARMs has inadvertently increased SR9009 adulteration risks.
●Long-Term Unknowns: Rev-ErbA's role in immune function raises theoretical concerns about prolonged use.
●User Reports: Complaints of diminished efficacy over time suggest receptor desensitization-a phenomenon not yet studied.
Comparative Analysis with Similar Agents
●vs. Cardarine (GW501516): While both enhance endurance, SR9009's circadian effects offer unique fat-loss timing precision.
●vs. SR9011: This analog has higher bioavailability but shorter research history, creating a trade-off between potency and safety data.
Future Directions and Research
Ongoing trials explore SR9009 in metabolic disorders, hinting at legitimate therapeutic potential. Bodybuilders monitor these studies for insights into off-label optimization.
Clinical Data
| Trade names |
SR9011,Stenabolic |
|
CAS |
1379686-29-9 |
|
Molar mass |
479.04 |
|
MF |
C23H31ClN4O3S |
|
Purity |
Above 98% |
|
Apprarance |
White Cyrstalline Powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
SR9009 represents a paradigm shift in performance enhancement, merging circadian biology with metabolic manipulation. Its non-hormonal profile and multifactorial benefits position it uniquely, though users must navigate regulatory and safety uncertainties. As research evolves, so will strategies to harness its full potential, underscoring the need for vigilance and innovation in supplementation practices.
Hot Tags: sarms sr9009 powder bodybuilding cas:1379686-30-2, China sarms sr9009 powder bodybuilding cas:1379686-30-2 manufacturers, suppliers, factory, MK2866 Treat Muscular Dystrophy and Osteoporosis, RAD150, MK2866, RAD140 increase lean muscle mass, RAD150 Promotes muscle growth, MK677 growth hormone secretion
